Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Paraneoplastic hormonal syndromes].

L Forga1, E Anda, J P Martínez de Esteban

  • 1Servicio de Endocrinología, Hospital de Navarra, Pamplona, 31008, Spain. lforgall@cfnavarra.es

Anales Del Sistema Sanitario De Navarra
|September 13, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of matrix metalloproteinase-10 levels and genetic variant rs17860955 with severe vascular complications in patients with type 1 diabetes: prospective cohort.

Journal of diabetes and its complications·2025
Same author

Longitudinal changes in Mediterranean diet and transition between different obesity phenotypes.

Clinical nutrition (Edinburgh, Scotland)·2019
Same author

[Incidence of type 1 diabetes in Navarre (2009-2016): higher in the southern regions of the autonomous community].

Anales del sistema sanitario de Navarra·2018
Same author

Evaluation of the efectiveness of a protocol designed to improve glycemic control in patients with hyperglycemia

Anales del sistema sanitario de Navarra·2016
Same author

Sex and age differences in the achievement of control targets in patients with type 2 diabetes: results from a population-based study in a South European region.

BMC family practice·2016
Same author

Acute exercise leads to increased HbA1c and fructosamine levels in athletes with type 1 diabetes.

The Journal of sports medicine and physical fitness·2015

Paraneoplastic hormonal syndromes arise from tumors and can mimic primary diseases, impacting patient care. Recognizing these syndromes is crucial for diagnosing underlying neoplasms and guiding treatment strategies.

Area of Science:

  • Endocrinology
  • Oncology
  • Internal Medicine

Background:

  • Paraneoplastic syndromes are effects distant from a tumor, not caused by metastases.
  • Hormonal paraneoplastic syndromes involve peptide secretion, cytokines, or other hormones acting in endocrine, paracrine, or autocrine ways.
  • These syndromes can be more severe than the primary tumor and may precede, accompany, or follow cancer diagnosis.

Purpose of the Study:

  • To review the significance of paraneoplastic hormonal syndromes.
  • To highlight their role in diagnosing occult malignancies.
  • To discuss their potential to mislead diagnosis and aid in tumor monitoring.

Main Methods:

  • Literature review focusing on paraneoplastic hormonal syndromes.
  • Discussion of specific syndromes including hypercalcemia, SIADH, ectopic Cushing's, acromegaly, hypoglycemia, and gynecomastia.

Related Experiment Videos

  • Brief mention of other relevant hormones like calcitonin, somatostatin, and VIP.

    • Main Results:

    • Paraneoplastic hormonal syndromes can be critical indicators of underlying cancer.
    • Recognition is vital for accurate diagnosis, preventing misdiagnosis of the primary tumor.
    • These syndromes can serve as biomarkers for monitoring tumor progression and treatment response.

    Conclusions:

    • Paraneoplastic hormonal syndromes are significant clinical entities with diagnostic and prognostic implications.
    • Understanding their mechanisms, though not fully elucidated, is key to improving patient outcomes.
    • Early identification and management are essential for addressing both the syndrome and the underlying neoplasm.